Literature DB >> 21735948

Physicians' medication prescribing in primary care in Riyadh City, Saudi Arabia. Literature review, part 2: rational prescribing.

T Khoja1, N A Qureshi, Y Neyaz, M A Magzoub, A Haycox, T Walley.   

Abstract

Unlike sub-optimal prescribing, rational prescribing, coupled with certain indicators, is associated with improved safety in drug use in terms of selecting appropriate drug for prescribing, better quality of life for patients and cost-effective care. Medication prescribing is a relatively unexplored area of research in Saudi Arabia and until now most studies have been in the secondary and tertiary health care system. This paper is the second of 3 review articles that form the background for a series of 5 interconnected studies of prescribing patterns and medication errors in the public and private primary health care sectors of Saudi Arabia. A MEDLINE search was conducted to identify papers published in peer-reviewed journals over the previous 3 decades. The paper reviews rational prescribing with its indicators, suboptimal prescribing, classification of medication errors, and how to achieve quality in health care prescribing worldwide and in Saudi Arabia.

Entities:  

Mesh:

Year:  2011        PMID: 21735948

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

1.  Community pharmacists' attitudes toward dispensing errors at community pharmacy setting in Central Saudi Arabia.

Authors:  Mohamed N Al-Arifi
Journal:  Saudi Pharm J       Date:  2013-05-29       Impact factor: 4.330

2.  Evaluation of Faculty and Non-faculty Physicians' Medication Errors in Outpatients' Prescriptions in Shiraz, Iran.

Authors:  Pegah Misagh; Afsaneh Vazin; Soha Namazi
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

3.  Primary health care physicians' prescribing patterns for children under five in Qassim, Saudi Arabia.

Authors:  Saulat Jahan; Abdullah Mohammed Al-Saigul; Salih Ahmed Hamdelsseed
Journal:  Prim Health Care Res Dev       Date:  2019-06-25       Impact factor: 1.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.